Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus

R. K. Burt; A. Marmont; R. Arnold; F. Heipe; G. S. Firestein; E. Carrier; B. Hahn; W. Barr; Y. Oyama; J. Snowden; K. Kalunian; A. Traynor

doi:10.1038/sj.bmt.1703943

Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus

R. K. Burt^*, A. Marmont, R. Arnold, F. Heipe, G. S. Firestein, E. Carrier, B. Hahn, W. Barr, Y. Oyama, J. Snowden, K. Kalunian, A. Traynor

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

At Northwestern University, a phase I/II trial of hematopoietic stem cell transplant (HSCT) for systemic lupus erythematosus (SLE) has shown promising results. A phase III HSCT trial is being developed to confirm efficacy of HSCT vs continuing the currently accepted standard of care, intravenous pulse cyclophosphamide.

Original language	English (US)
Pages (from-to)	S49-S51
Journal	Bone Marrow Transplantation
Volume	32
DOIs	https://doi.org/10.1038/sj.bmt.1703943
State	Published - Aug 2003
Externally published	Yes

Keywords

Hematopoietic stem cell transplantation
Lupus

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1038/sj.bmt.1703943

Cite this

@article{e498278563c4471d9236d62f80ee3f9a,

title = "Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus",

abstract = "At Northwestern University, a phase I/II trial of hematopoietic stem cell transplant (HSCT) for systemic lupus erythematosus (SLE) has shown promising results. A phase III HSCT trial is being developed to confirm efficacy of HSCT vs continuing the currently accepted standard of care, intravenous pulse cyclophosphamide.",

keywords = "Hematopoietic stem cell transplantation, Lupus",

author = "Burt, {R. K.} and A. Marmont and R. Arnold and F. Heipe and Firestein, {G. S.} and E. Carrier and B. Hahn and W. Barr and Y. Oyama and J. Snowden and K. Kalunian and A. Traynor",

year = "2003",

month = aug,

doi = "10.1038/sj.bmt.1703943",

language = "English (US)",

volume = "32",

pages = "S49--S51",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus

AU - Burt, R. K.

AU - Marmont, A.

AU - Arnold, R.

AU - Heipe, F.

AU - Firestein, G. S.

AU - Carrier, E.

AU - Hahn, B.

AU - Barr, W.

AU - Oyama, Y.

AU - Snowden, J.

AU - Kalunian, K.

AU - Traynor, A.

PY - 2003/8

Y1 - 2003/8

N2 - At Northwestern University, a phase I/II trial of hematopoietic stem cell transplant (HSCT) for systemic lupus erythematosus (SLE) has shown promising results. A phase III HSCT trial is being developed to confirm efficacy of HSCT vs continuing the currently accepted standard of care, intravenous pulse cyclophosphamide.

AB - At Northwestern University, a phase I/II trial of hematopoietic stem cell transplant (HSCT) for systemic lupus erythematosus (SLE) has shown promising results. A phase III HSCT trial is being developed to confirm efficacy of HSCT vs continuing the currently accepted standard of care, intravenous pulse cyclophosphamide.

KW - Hematopoietic stem cell transplantation

KW - Lupus

UR - http://www.scopus.com/inward/record.url?scp=10744233855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744233855&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1703943

DO - 10.1038/sj.bmt.1703943

M3 - Article

C2 - 12931242

AN - SCOPUS:10744233855

SN - 0268-3369

VL - 32

SP - S49-S51

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

ER -

Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this